|
VIOXX® News Archive
Bloomberg.com  Merck's Gilmartin Rejects Claims VIOXX® Risk Ignored
CBSNews.com Prescription For Trouble
CNN.com Merck CEO Shoots Back on VIOXX®
Food and Drug Administration FDA Issues Public Health Advisory on VIOXX® as its Manufacturer Voluntarily
Withdraws the Product
Memorandum from David J. Graham, MD, MPH, Associate Director for Science, Office of Drug Safety
FDA Approves New Indication and Label Changes
for the Arthritis Drug, VIOXX®
FDA Approves VIOXX® For Osteoarthritis, Pain And Menstrual Pain
Lancet VIOXX®, the Implosion of Merck, and Aftershocks at the FDA
VIOXX®: An Unequal Partnership Between Safety and Efficacy
Merck and Co., Inc. Merck Announces Voluntary Worldwide Withdrawal of VIOXX®
VIOXX® Prescription Information
MSNBC.com FDA Has Been Asleep at the Switch
New England Journal of Medicine Failing the Public Health — Rofecoxib, Merck, and the FDA
New York Times Despite Warnings, Drug Giant Took Long Path to VIOXX® Recall
Reuters Merck Knew VIOXX® Was Unsafe by 2000 - Report
WashingtonPost.com FDA Bars Critic From Meeting
Two Agencies Probe Merck's Handling of Its VIOXX® Drug
Yahoo! Merck Heads to Capitol Hill for VIOXX® Hearing
|
